01 February 2006
Hepatotoxicity of chloroquine treatment in patient with porphyria cutanea tarda
Piotr Stalke, Katarzyna Sikorska, Zofia Michalska, Julian Stolarczyk, Hanna TrochaCase Rep Clin Pract Rev 2006; 7:18-22 :: ID: 445545
Abstract
Background: Porphyria cutanea tarda (PCT) is a disorder of porphyrin metabolism associated with decreased activity of uroporphyrinogen decarboxylase (URO-D) activity in liver. There are two main
options of PCT therapy: phlebotomy and chloroquine administration, however, some side effects were described in both.
Case Report: A 50-year-old Caucasian man was admitted to hospital because of symptoms of severe liver
damage, fever up to 39,5ºC with chills, and vesicular eruptions. A month before the patient had developed erythema on the face and hands that left flat erosions. PCT was diagnosed and the patient was treated with chloroquine 500 mg/daily, prednisone 5 mg/daily, and ornithine 450 mg/daily. After a week of treatment, he had developed headaches, nausea, vomiting, fever and subicterus. On admission to hospital hypertrichosis involving the face, dry and reddened skin on the sun-exposed-areas with many crusts and ruptured bullas – some of which had eroded, and enlarged liver were found. The patient’s urine was dark red. Laboratory tests suggested severe
liver damage with haemostatic disorders and hyperleucocytosis. Urine level of porphyrins was
elevated. Histological study of the skin biopsy material revealed deposits of immunoglobulins.
Liver biopsy showed macrovesicular steatosis and iron deposits in hepatocytes. Septicaemia, viral and autoimmune hepatitis were excluded. In view of the clinical aspects the diagnosis of toxic liver damage after chloroquine treatment during the course of PTC was made. The patient was treated with glucose infusion, prednisone, fresh frozen plasma and he resolved.
Conclusions: The symptoms of severe liver damage similar to the acute viral hepatitis could be observed after chloroquine treatment in patient with PCT.
Keywords: Porphyria Cutanea Tarda, Chloroquine, Hemosiderosis, Hepatitis, toxic
19
In Press
12 Feb 2024 : Case report
Diagnostic Challenges and Imaging Considerations for Intraparotid Facial Nerve Schwannoma: A Case Report an...Am J Case Rep In Press; DOI: 10.12659/AJCR.942870
12 Feb 2024 : Case report
Erdheim-Chester Disease Occult on Radiographs and CT but Visible on MRI and PETAm J Case Rep In Press; DOI: 10.12659/AJCR.941169
12 Feb 2024 : Case report
Surgical Treatment of Spontaneous Superficial Temporal Artery Arteriovenous Malformation: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942839
13 Feb 2024 : Case report
Warfarin Woes: A Rare Case of Hemoperitoneum with Intramural Small Bowel HematomaAm J Case Rep In Press; DOI: 10.12659/AJCR.943519
Most Viewed Current Articles
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
05 Mar 2022 : Case report
Acute Limb Ischemia After Self-Injection of Crushed Morphine Tablets into the Radial Artery: Role of Infrar...DOI :10.12659/AJCR.935336
Am J Case Rep 2022; 23:e935336
02 Apr 2022 : Case report
Infective Endocarditis Caused by Pseudomonas luteola in a Pediatric Patient. A Case Report and Review of Li...DOI :10.12659/AJCR.935743
Am J Case Rep 2022; 23:e935743